Eva Bubanská
Impact in
-
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
-
- Immunodeficiency and Autoimmune Disorders
Papers in
-
- Acute Lymphoblastic Leukemia research 7
-
- Acute Myeloid Leukemia Research 4
- Platelet Disorders and Treatments 2
- Hemophilia Treatment and Research 1
- Co-authors
- Cáp J (3 shared papers)V. Krčméry (1 shared paper)J. Trupl (1 shared paper)Laura Dotta (1 shared paper)Alessandro Plebani (1 shared paper)Marcella Visentini (1 shared paper)Raffaele Badolato (1 shared paper)Smith Rjh (1 shared paper)
In The Last Decade
Eva Bubanská
12 papers receiving 107 citations
Peers
Comparison fields: 5 of 32
- Hematology 34
- Immunology 28
- Infectious Diseases 21
- Oncology 30
- Public Health, Environmental and Occupational Health 24
Countries citing papers authored by Eva Bubanská
This map shows the geographic impact of Eva Bubanská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Bubanská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Bubanská more than expected).
Fields of papers citing papers by Eva Bubanská
This network shows the impact of papers produced by Eva Bubanská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Bubanská. The network helps show where Eva Bubanská may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Bubanská, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 34 | |
| 2 | 1993 | 19 | |
| 3 | 2016 | 11 | |
| 4 | 2019 | 10 | |
| 5 | 2010 | 7 | |
| 6 | 2012 | 6 | |
| 7 | 2011 | 6 | |
| 8 | 2019 | 4 | |
| 9 | 1993 | 4 | |
| 10 | Heart transplant in a childhood leukemia survivor: a case report. | 2010 | 3 |
| 11 | 2012 | 3 | |
| 12 | Capizzi methotrexate with BFM backbone without craniospinalirradiation is effective treatment for pediatric lymphoblasticlymphoma: results from 5 countries with I-BFM LL 09 protocol | 2015 | 3 |
| 13 | 2015 | 0 |
About Eva Bubanská
Eva Bubanská is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Pediatrics, Perinatology and Child Health, Oncology and Molecular Biology, having authored 13 papers that have together received 110 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Neutropenia and Cancer Infections (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Platelet Disorders and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Hemophilia Treatment and Research (1 paper). The work is most often cited by research in Hematology (34 citations), Immunology (28 citations), Infectious Diseases (21 citations), Oncology (30 citations) and Public Health, Environmental and Occupational Health (24 citations). Eva Bubanská has collaborated with scholars based in Slovakia, Czechia and Poland. Frequent co-authors include Cáp J, V. Krčméry, J. Trupl, Laura Dotta, Alessandro Plebani, Marcella Visentini, Raffaele Badolato, Smith Rjh, Patrizia Bertolini and Aldo Venuti. Their work appears in journals such as Seminars in Thrombosis and Hemostasis, Blood Cells Molecules and Diseases, Chemotherapy, The Journal of Allergy and Clinical Immunology In Practice and Neoplasma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.